Li, Yanbing
Huang, Kangkang
Yin, Jun
Tan, Zheren
Zhou, Manli
Dai, Jiaoyang
Yi, Bin
Funding for this research was provided by:
Natural Science Foundation of Hunan Province (2023JJ30905, 2023JJ30905)
Article History
Received: 28 August 2023
Accepted: 5 December 2023
First Online: 21 December 2023
Declarations
:
: The authors declare that they have no competing interests.
: The institutional review boards at the XHCSU approved the study protocol. The medical ethics committee's responsibilities, composition, operations and records are fully compliant with “Guidelines for ethical review of drug clinical trials” (2010), “Methods for ethical review of biomedical research involving human beings” (2016), “Standard for quality control of clinical trials of medical devices” (2016), GCP (2020), ICH-GCP and other related regulations. All participants gave a written informed consent prior to their inclusion in the study and the data were analyzed anonymously.